ELATIVE Trial: Study design & baseline characteristics
The ELATIVE trial is a double-blind, randomised, placebo-controlled study to evaluate the efficacy and safety of IQIRVO in patients with PBC and inadequate response or intolerance to UDCA5
IQV-UK-000158 | January 2025

